The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. 'Protein modifications: beyond the usual suspects' review series.

EMBO Rep

Autoimmunity, Transplantation and Inflammation, Novartis Pharma AG, Forum 1, Novartis Campus, Basel CH-4056, Switzerland.

Published: August 2008

The intracellular modification of proteins by the addition of a single O-linked N-acetylglucosamine (O-GlcNAc) molecule is a ubiquitous post-translational modification in eukaryotic cells. It is catalysed by O-linked N-acetylglucosaminyltransferase, which attaches O-GlcNAc to serine/threonine residues, and it is counter-regulated by beta-N-acetylglucosaminidase, which is the antagonistic glycosidase that removes the O-GlcNAc group. O-GlcNAc modification competes with phosphorylation by protein kinases at similar sites, thereby affecting important signalling nodes. Accumulating evidence supports a central role for O-GlcNAc modifications and the corresponding enzymes in the regulation of immune cells, particularly in the activation processes of T and B lymphocytes. Here, we discuss recent advances in the field of O-GlcNAc modifications, focusing on the cells of the immune system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515212PMC
http://dx.doi.org/10.1038/embor.2008.129DOI Listing

Publication Analysis

Top Keywords

o-linked n-acetylglucosamine
8
immune system
8
o-glcnac modifications
8
o-glcnac
6
modification
4
n-acetylglucosamine modification
4
modification cellular
4
cellular signalling
4
signalling immune
4
system 'protein
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!